Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08QCQ
|
||||
| Former ID |
DNC014744
|
||||
| Drug Name |
4-(5-tert-Butyl-[1,3]dithian-2-yl)-benzonitrile
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C15H19NS2
|
||||
| Canonical SMILES |
CC(C)(C)C1CSC(SC1)C2=CC=C(C=C2)C#N
|
||||
| InChI |
1S/C15H19NS2/c1-15(2,3)13-9-17-14(18-10-13)12-6-4-11(8-16)5-7-12/h4-7,13-14H,9-10H2,1-3H3
|
||||
| InChIKey |
JBVUMTNJGGTVQA-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Gamma-aminobutyric acid receptor | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | J Med Chem. 1995 Jul 7;38(14):2663-71.Synthesis of carbon-11-, fluorine-18-, and iodine-125-labeled GABAA-gated chloride ion channel blockers: substituted 5-tert-butyl-2-phenyl-1,3-dithianes and -dithiane oxides. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.